This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Syntekabio, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: **Jaemin Seol: Innovator in AI-Driven Biomarker Discovery**
Introduction
Jaemin Seol, an accomplished inventor based in Daejeon, South Korea, has made significant contributions to the field of artificial intelligence and genomics. With a focus on utilizing advanced technology for scientific progress, he has demonstrated a keen ability to blend innovative thinking with practical applications in biotech.
Latest Patents
Seol holds a patent for his groundbreaking invention titled "Hilbert-CNN: AI-Driven Convolutional Neural Networks with Conversion Data of Genome for Biomarker Discovery." This innovative method aims at detecting biomarkers by employing an artificial intelligence deep learning model that processes conversion data of nucleotide sequences and population genome mutations. His method includes collecting nucleotide sequences, generating conversion data reflecting diploid genome mutations, and implementing a fully connected network to extract valuable biomarkers effectively.
Career Highlights
Currently, Jaemin Seol is part of Syntekabio, Inc., where he actively contributes to cutting-edge research and development in biotechnology. His work continues to advance the capabilities of AI in the biomedical field, reflecting his dedication to enhancing health and diagnostics through technology.
Collaborations
Throughout his career, Seol has exemplified the spirit of collaboration, working alongside esteemed colleagues such as Jongsun Jung and Jaeyun Yoo. Their collective efforts within Syntekabio, Inc. have focused on pushing the boundaries of what is possible in genomic research and biomarker identification.
Conclusion
Jaemin Seol is a promising inventor whose work in AI-driven biomarker discovery is set to influence the landscape of medical technology. His innovative approach combines deep learning with genomic data, offering new insights into the detection of biomarkers that could lead to breakthroughs in health diagnostics and treatment strategies. As he continues to collaborate with fellow innovators, the impact of his contributions is sure to be significant and far-reaching.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile